Evidence map›Paper›PMID 37087820›Full record

ArticleNeuroImage. Clinical2023

Symptomatology in 4-repeat tauopathies is associated with data-driven topology of [

Sonja Schönecker, Carla Palleis, Nicolai Franzmeier, Sabrina Katzdobler, Christian Ferschmann, Sebastian Schuster, Anika Finze, Maximilian Scheifele, Catharina Prix, Urban Fietzek and 11 more

Open access · goldAbstract read
In one paragraph

Article in NeuroImage. Clinical, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. First-in-human PET neuroimaging of [European journal of nuclear medicine and molecular imaging · 2025
    Article
  3. Developing a novel reference region for [European journal of nuclear medicine and molecular imaging · 2025
    Article
  4. Article
  5. Review
  6. Radiosynthesis,ACS chemical neuroscience · 2025
    Article
  7. Ligand-based design of [Nature communications · 2024
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 4 institutions in 1 country.

Sonja SchöneckerDepartment of Neurology, Ludwig-Maximilians-Universität München, LMU Munich, Munich, Germany.
Carla PalleisDepartment of Neurology, Ludwig-Maximilians-Universität München, LMU Munich, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
Nicolai FranzmeierMunich Cluster for Systems Neurology (SyNergy), Munich, Germany; Institute for Stroke and Dementia Research, Ludwig-Maximilians-Universität München, LMU München, Munich, Germany.
Sabrina KatzdoblerDepartment of Neurology, Ludwig-Maximilians-Universität München, LMU Munich, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
Christian FerschmannDepartment of Nuclear Medicine, Ludwig-Maximilians-Universität München, LMU Munich, Munich, Germany.
Sebastian SchusterDepartment of Nuclear Medicine, Ludwig-Maximilians-Universität München, LMU Munich, Munich, Germany.
Anika FinzeDepartment of Nuclear Medicine, Ludwig-Maximilians-Universität München, LMU Munich, Munich, Germany.
Maximilian ScheifeleDepartment of Nuclear Medicine, Ludwig-Maximilians-Universität München, LMU Munich, Munich, Germany.
Catharina PrixDepartment of Neurology, Ludwig-Maximilians-Universität München, LMU Munich, Munich, Germany.
Urban FietzekDepartment of Neurology, Ludwig-Maximilians-Universität München, LMU Munich, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; Department of Neurology and Clinical Neurophysiology, Schön Klinik München Schwabing, Munich, Germany.
Endy WeidingerDepartment of Neurology, Ludwig-Maximilians-Universität München, LMU Munich, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Georg NüblingDepartment of Neurology, Ludwig-Maximilians-Universität München, LMU Munich, Munich, Germany.
Jonathan VögleinDepartment of Neurology, Ludwig-Maximilians-Universität München, LMU Munich, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Marianne PattDepartment of Nuclear Medicine, University Hospital of Leipzig, Leipzig, Germany.
Henryk BarthelDepartment of Nuclear Medicine, University Hospital of Leipzig, Leipzig, Germany.
Osama SabriDepartment of Nuclear Medicine, University Hospital of Leipzig, Leipzig, Germany.
Adrian DanekDepartment of Neurology, Ludwig-Maximilians-Universität München, LMU Munich, Munich, Germany.
Günter U HöglingerGerman Center for Neurodegenerative Diseases (DZNE), Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany; European Reference Network for Rare Neurological Diseases (ERN-RND), Munich, Germany; Department of Neurology, Hannover Medical School, Hannover, Germany.
Matthias BrendelGerman Center for Neurodegenerative Diseases (DZNE), Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany; Department of Nuclear Medicine, Ludwig-Maximilians-Universität München, LMU Munich, Munich, Germany.
Johannes LevinDepartment of Neurology, Ludwig-Maximilians-Universität München, LMU Munich, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany; European Reference Network for Rare Neurological Diseases (ERN-RND), Munich, Germany. Electronic address: jlevin@med.uni-muenchen.de.
for German Imaging Initiative for Tauopathies GII4T
German Center for Neurodegenerative Diseases · DELudwig-Maximilians-Universität München · DEUniversity Hospital Leipzig · DEMunich Cluster for Systems Neurology · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years in vivo visualization of tau deposits has become possible with various PET radiotracers. The tau tracer [

Indexed as

Movement DisordersSupranuclear Palsy, ProgressiveConfusionHumansPositron-Emission TomographyPyridinestau ProteinsPI-2620Pyridinestau Proteins[(18)F]PI-2620 tau-PET4-repeat tauopathyCorticobasal syndromeData-drivenParkinsonismProgressive supranuclear palsy

Identifiers

PMID37087820
PMCPMC10300609
OpenAlexW4364355570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.